Skip to content

Positive Allosteric Modulation of the 5-HT1A Receptor by Indole-Based Synthetic Cannabinoids Abused by Humans

Hideaki Yano, Pramisha Adhikari, Sett Naing, Alexander F. Hoffman, Michael H. Baumann, Carl R. Lupica, Lei Shi

ACS Chemical Neuroscience April 23, 2020 DOI: 10.1021/acschemneuro.0c00034 (opens in new tab)

Study at a glance

AI-extracted from the abstract
Characteristics Experimental study Peer reviewed
Population Mice lacking cannabinoid receptor 1, and neurons in vitro
Interventions AM2201 JWH-018
Keywords Allosteric regulation Allosteric modulator Pharmacology Agonist Mechanism of action Cannabinoid receptor In vitro Biochemistry
Citations 26
Key findings Indole-moiety containing synthetic cannabinoids AM2201 and JWH-018 act as positive allosteric modulators at the 5-HT1A receptor, potentiating its effects.

Abstract

The nonmedical (i.e., recreational) misuse of synthetic cannabinoids (SCs) is a worldwide public health problem. When compared to cannabis, the misuse of SCs is associated with a higher incidence of serious adverse effects, suggesting the possible involvement of noncannabinoid sites of action. Here, we find that, unlike the phytocannabinoid Δ9-tetrahydrocannabinol, the indole-moiety containing SCs, AM2201 and JWH-018, act as positive allosteric modulators (PAMs) at the 5-HT1A receptor (5-HT1AR). This suggests that some biological effects of SCs might involve allosteric interactions with 5-HT1ARs. To test this hypothesis, we examined effects of AM2201 on 5-HT1AR agonist-activated G protein-coupled inwardly rectifying potassium channel currents in neurons in vitro and on the hypothermic response to 5-HT1AR stimulation in mice lacking the cannabinoid receptor 1. We found that both 5-HT1AR effects were potentiated by AM2201, suggesting that PAM activity at 5-HT1AR may represent a novel noncannabinoid receptor mechanism underlying the complex profile of effects for certain SCs.

Citations in the library

Explore topics